CURX
Curanex Pharmaceuticals Inc Common Stock
NASDAQ · Healthcare · Biotechnology · US
$5.16
+8.86%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-218.7%
Return on equity
-206.3%
Return on assets
-208.4%
Return on invested capital
0.00x
Asset turnover
-$12.1M
Cash from operations
$1.87
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026